Tiziana Life Sciences is a biotechnology company focused on the development of novel therapeutics for various diseases. With a strong pipeline and innovative approach, the company aims to address unmet medical needs and improve patient outcomes. Their common shares offer investors the opportunity to support and potentially benefit from their groundbreaking research and development efforts.
